Advertisement

Topics

Enrollment started for Phase III trial of Rigel's AIHA treatment

05:47 EDT 17 May 2019 | SmartBrief

Rigel Pharmaceuticals has started enrollment for patients participating in its late-stage clinical study to evaluate its drug -More

Original Article: Enrollment started for Phase III trial of Rigel's AIHA treatment

NEXT ARTICLE

More From BioPortfolio on "Enrollment started for Phase III trial of Rigel's AIHA treatment"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

BioPortfolio - life science, medical devices and pharmaceutical conference
BioPortfolio is a leading news, information and knowledge resource covering the global life science industries impacted on by biotechnology. The site aims to provide the lay person, the researcher and the management executive with a single location to so...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...